Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing.
Leadership & Board
Current Number of Employees102
Current LinkedIn Followers6,354
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$60M
Total Amount Raised$60M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$60M
Latest Funding Amount$60M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Rani Therapeutics had 102 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
102Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Rani Therapeutics had 6,354 followers as of September 28, 2026. The number of followers increased by 11 (0.17%) week-over-week.
6,354Latest Followers Count
11(0.17%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.